Cargando…
Carbamylated erythropoietin attenuates cardiomyopathy via PI3K/Akt activation in rats with diabetic cardiomyopathy
The aim of the present study was to investigate the protective effect of carbamylated erythropoietin (CEPO) against cardiomyopathy in high-fat, high-carbohydrate diet-fed rats with streptozotocin (STZ)-induced diabetic cardiomyopathy (DCM). Healthy male Wistar rats were fed a high-fat, high-carbohyd...
Autores principales: | HE, HONGYING, QIAO, XIAOYU, WU, SUISHENG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786988/ https://www.ncbi.nlm.nih.gov/pubmed/24137228 http://dx.doi.org/10.3892/etm.2013.1134 |
Ejemplares similares
-
Molecular mechanism of the role of carbamyl erythropoietin in treating diabetic retinopathy rats
por: Xu, Xuegu, et al.
Publicado: (2018) -
Carbamylated erythropoietin regulates immune responses and promotes long-term kidney allograft survival through activation of PI3K/AKT signaling
por: Na, Ning, et al.
Publicado: (2020) -
Carvacrol Attenuates Diabetic Cardiomyopathy by Modulating the PI3K/AKT/GLUT4 Pathway in Diabetic Mice
por: Hou, Ning, et al.
Publicado: (2019) -
Spinal Stroke: Outcome Attenuation by Erythropoietin and Carbamylated Erythropoietin and Its Prediction by Sphingosine-1-Phosphate Serum Levels in Mice
por: Koepke, Leon-Gordian, et al.
Publicado: (2022) -
Carbamylated Erythropoietin: A Prospective Drug Candidate for Neuroprotection
por: Chen, Jianmin, et al.
Publicado: (2016)